The evidence that diabetes mellitus causes a pro-inflammatory environment has been corroborated by serum levels of inflammation biomarkers, such as interleukin-6 (IL-6), C-reactive protein (CRP), and ferritin, and D-dimer that are markedly higher in COVID-19 patients with diabetes mellitus compared to controls without diabetes [51]. The gene discussed is IL6; the disease is diabetes mellitus.